Study Purpose: Researchers want to see if the drug ASN51 is safe and works well for adults with early Alzheimer's disease, which affects memory and thinking. They will look at how the body handles the drug and its impact on disease markers.

Eligibility: Adults aged 50-80 with mild Alzheimer's symptoms can join. They need a helper who knows them well to assist with the study. Participants cannot have other brain conditions or be women who can become pregnant. Also, they shouldn't have had certain Alzheimer's treatments before.

• The study includes multiple doses of ASN51.
• Participants must attend several visits for evaluations.
• There are certain eligibility criteria that need to be met, and some risks could be involved.

Note: Other specific criteria might apply, and details will be provided by the study team.